Dec. 13, 2018—Quest Diagnostics has signed a definitive agreement to acquire the assets of the clinical laboratory services business of Boyce and Bynum Pathology Laboratories; BBPL’s anatomic pathology division, long-term care division, and Boyce and Bynum Pathology Professional Services are not part of the transaction. Through a separate professional services agreement, BBPPS will become the exclusive pathology provider for Quest clients in Missouri and a preferred pathology provider in the greater Midwestern region.
“BBPL and Quest have complementary strengths that will improve access to superior diagnostic innovation by combining the anatomic pathology capabilities and clinical expertise of BBPPS and Quest,” Michael D. Curry, MD, PhD, medical director, president, and CEO of BBPL, said in a press release. “We are confident that Quest is the right organization to build on the progress and vision of BBPL to empower better health for patients in the Midwest.”
The professional services agreement will go into effect when the acquisition is completed, which is expected in the first quarter of 2019.